Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Mercola

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Oncogene|June 25, 1999
p53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosisI de Belle, R P Huang, Y Fan, et al.
Molecular and Cellular Biology|August 1, 1992
Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73T Smeal, B Binetruy, D Mercola, et al.
The Biochemical Journal|December 1, 1971
The structure and biology of insulinT L Blundell, J F Cutfield, G G Dodson, et al.
Nature Cell Biology|January 10, 2002
The Egr-1 transcription factor directly activates PTEN during irradiation-induced signallingT Virolle, E D Adamson, V Baron, et al.
Oncogene|July 1, 1990
The proto-oncogene c-fos is over-expressed in the majority of human osteosarcomasJ X Wu, P M Carpenter, C Gresens, et al.
The Journal of Biological Chemistry|May 29, 2000
c-Jun N-terminal kinase is essential for growth of human T98G glioblastoma cellsO Potapova, M Gorospe, F Bost, et al.
The Journal of Biological Chemistry|October 26, 1999
Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell lineJ Hayakawa, M Ohmichi, H Kurachi, et al.
International Journal of Cancer|July 3, 1997
Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formationR P Huang, Y Fan, I de Belle, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 1996
Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapyH Fakhrai, O Dorigo, D L Shawler, et al.
Molecular Carcinogenesis|December 1, 1995
Use of wild-type p53 to achieve complete treatment sensitization of tumor cells expressing endogenous mutant p53R A Gjerset, S T Turla, R E Sobol, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Oncogene|June 25, 1999
p53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosisI de Belle, R P Huang, Y Fan, et al.
Molecular and Cellular Biology|August 1, 1992
Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73T Smeal, B Binetruy, D Mercola, et al.
The Biochemical Journal|December 1, 1971
The structure and biology of insulinT L Blundell, J F Cutfield, G G Dodson, et al.
Nature Cell Biology|January 10, 2002
The Egr-1 transcription factor directly activates PTEN during irradiation-induced signallingT Virolle, E D Adamson, V Baron, et al.
Oncogene|July 1, 1990
The proto-oncogene c-fos is over-expressed in the majority of human osteosarcomasJ X Wu, P M Carpenter, C Gresens, et al.
The Journal of Biological Chemistry|May 29, 2000
c-Jun N-terminal kinase is essential for growth of human T98G glioblastoma cellsO Potapova, M Gorospe, F Bost, et al.
The Journal of Biological Chemistry|October 26, 1999
Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell lineJ Hayakawa, M Ohmichi, H Kurachi, et al.
International Journal of Cancer|July 3, 1997
Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formationR P Huang, Y Fan, I de Belle, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 1996
Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapyH Fakhrai, O Dorigo, D L Shawler, et al.
Molecular Carcinogenesis|December 1, 1995
Use of wild-type p53 to achieve complete treatment sensitization of tumor cells expressing endogenous mutant p53R A Gjerset, S T Turla, R E Sobol, et al.
Pageof 6